Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit

Bibliographic Details
Main Authors:	Tooth, David, Garsed, Klara, Singh, Gulzar, Marciani, Luca, Lam, Ching, Fordham, Imogen, Fields, Annie, Banwait, Rawinder, Lingaya, Melanie, Layfield, Robert, Hastings, Maggie, Whorwell, Peter, Spiller, Robin C.
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2014
Online Access:	http://eprints.nottingham.ac.uk/3086/ http://eprints.nottingham.ac.uk/3086/ http://eprints.nottingham.ac.uk/3086/ http://eprints.nottingham.ac.uk/3086/1/2014_Gut_faecal_protease_activity_IBS.pdf

Similar Items

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit
by: Tooth, David, et al.
Published: (2014)

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
by: Garsed, Klara, et al.
Published: (2014)

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
by: Garsed, Klara, et al.
Published: (2013)

A mechanistic multi-centre, parallel group, randomised placebo controlled trial of Mesalazine for treatment of irritable bowel syndrome with diarrhoea (IBS-D)
by: Lam, Ching, et al.
Published: (2015)

Predicting the response to Ondansetron, a 5HT3 receptor antagonist, in irritable bowel syndrome with diarrhoea: the utility of clinical features and objective biomarkers
by: Garsed, Klara C.
Published: (2014)

Faecal incontinence—the hidden scourge of irritable bowel syndrome: a cross-sectional study
by: Atarodi, Sima, et al.
Published: (2015)

A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D)
by: Lam, Ching, et al.
Published: (2016)

Corticotrophin releasing factor increases ascending colon volume after a fructose test meal in healthy humans: a randomised control trial
by: Murray, Kathryn, et al.
Published: (2016)

Effect of experimental stress on the small bowel and colon in healthy humans
by: Pritchard, SE, et al.
Published: (2015)

Fasting and postprandial volumes of the undisturbed colon: normal values and changes in diarrhea-predominant irritable bowel syndrome measured using serial MRI
by: Pritchard, Susan E., et al.
Published: (2013)

Fasting and postprandial volumes of the undisturbed colon: normal values and changes in diarrhea-predominant irritable bowel syndrome measured using serial MRI
by: Pritchard, S E, et al.
Published: (2014)

Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome
by: Emmanuel, Anton, et al.
Published: (2016)

Colonic response to laxative ingestion as assessed by MRI differs in constipated irritable bowel syndrome compared to functional constipation
by: Lam, C., et al.
Published: (2016)

Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial
by: Leighton, Matthew P, et al.
Published: (2013)

Association between faecal load of lawsonia intracellularis and pathological findings of proliferative enteropathy in pigs with diarrhoea
by: Pedersen, Ken Steen, et al.
Published: (2012)

Evaluation of farmers’ diagnostic performance for detection of diarrhoea in nursery pigs using digital pictures of faecal pools
by: Pedersen, Ken S, et al.
Published: (2013)

Irritable bowel syndrome, inflammatory bowel disease and the microbiome
by: Major, Giles, et al.
Published: (2014)

Colonic response to laxative ingestion as assessed by MRI differs in constipated irritable bowel syndrome compared to functional constipation
by: Lam, C., et al.
Published: (2016)

Irritable bowel syndrome, inflammatory bowel disease and the microbiome
by: Major, Giles, et al.
Published: (2014)

Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in individuals with irritable bowel syndrome
by: Major, Giles, et al.
Published: (2017)

Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment
by: Spiller, Robin
Published: (2016)

Low prevalence of ‘classical’ microscopic colitis but evidence of microscopic inflammation in Asian Irritable Bowel Syndrome patients with diarrhoea
by: Hilmi, Ida, et al.
Published: (2013)

Randomized Clinical Trial: The Clinical Effects of Herb-Partitioned Moxibustion in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome
by: Ma, Yu-xia, et al.
Published: (2013)

Randomised clinical trial: exploratory phase 2 study of ONO‐2952 in diarrhoea‐predominant irritable bowel syndrome
by: Whitehead, W. E., et al.
Published: (2016)

Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients
by: Nagel, Robyn, et al.
Published: (2016)

Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?
by: Farup, Per G., et al.
Published: (2016)

Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases
by: Ceuleers, Hannah, et al.
Published: (2016)

Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome
by: Liang, Wen-Jing, et al.
Published: (2016)

Probiotics for diarrhoea
by: Hempel, Susanne
Published: (2014)

Hill Diarrhœa
by: Crozier, G. G.
Published: (1906)

Diarrhœa Alba
Published: (1893)

Infantile Diarrhœa
by: Thakuria, H.
Published: (1948)

Infantile Diarrhœa
by: Khan, M. Maswood
Published: (1947)

Hill Diarrhœa
by: Lees, L. H.
Published: (1871)

Hill Diarrhœa
by: Barry, J.
Published: (1888)

On the Diarrhœa of Infants
Published: (1866)

On the Diarrhœa of Infants
Published: (1866)

Fæcal Impaction
Published: (1901)

Fæcal Anæmia
by: Hehir,
Published: (1890)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
by: Padhy, Susanta Kumar, et al.
Published: (2015)